体外心肺复苏与标准治疗对难治性院外心脏骤停的对比:一项贝叶斯Meta分析
该贝叶斯Meta分析纳入3项随机试验(ECPR组209例,传统CPR组211例),比较ECPR与传统CPR对难治性院外心脏骤停患者6个月神经功能良好存活的影响。全部心律患者中,ECPR的相对危险度中位数为1.47(95%CrI 0.73-3.32),平均绝对风险差为8.7%(-5.0; 42.7%);可电击心律患者中,相对危险度中位数为1.54(95%CrI 0.79-3.71),平均绝对风险差为10.8%(95%CrI -4.2; 73.9%)。全部心律和可电击心律患者中,绝对风险差>0%的后验概率分别为91.0%和92.4%,>5%的后验概率分别为71.1%和75.8%。作者认为,这些结果需在报告的可信区间和随机试验设计差异的背景下解读。
要点
- 在全部心律的难治性院外心脏骤停患者中,ECPR对6个月神经功能良好存活的相对危险度中位数为1.47(95%CrI 0.73-3.32),平均绝对风险差为8.7%(-5.0; 42.7%)。
- 在可电击心律患者中,ECPR的相对危险度中位数为1.54(95%CrI 0.79-3.71),平均绝对风险差为10.8%(95%CrI -4.2; 73.9%)。
- 全部心律患者中,绝对风险差>0%和>5%的后验概率分别为91.0%和71.1%;可电击心律患者中分别为92.4%和75.8%。
- 作者结论指出,这些结果需在报告的可信区间和随机试验设计差异的背景下解读。
适用人群与场景
- 难治性院外心脏骤停患者,纳入比较ECPR为基础的治疗与传统CPR的随机试验。
研究设计与关键结果
- 研究类型:贝叶斯Meta分析,纳入3项随机试验(ECPR组n=209,传统CPR组n=211)。
- 主要终点:全部心律患者6个月神经功能良好存活,ECPR的相对危险度中位数为1.47(95%CrI 0.73-3.32),平均绝对风险差为8.7%(-5.0; 42.7%)。
- 次要分析:可电击心律患者6个月神经功能良好存活,相对危险度中位数为1.54(95%CrI 0.79-3.71),平均绝对风险差为10.8%(95%CrI -4.2; 73.9%)。
- 后验概率:全部心律患者绝对风险差>0%和>5%的后验概率分别为91.0%和71.1%;可电击心律患者分别为92.4%和75.8%。
证据类型、等级与局限
- 证据类型:贝叶斯Meta分析(系统检索3个电子数据库,纳入随机试验)。
- 研究方案在INPLASY预注册(INPLASY2023120060,2023年12月14日)。
- 主要贝叶斯分析在模糊先验下进行,采用贝叶斯分层随机效应模型。
- 局限:作者指出结果需在报告的可信区间和随机试验设计差异的背景下解读。
对床旁实践的改变
- 作者认为,当前贝叶斯Meta分析发现ECPR对6个月神经功能良好存活具有临床相关治疗效应的后验概率在全部心律和可电击心律患者中分别为71.1%和75.8%,这些结果需在报告的可信区间和随机试验设计差异的背景下解读。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The outcomes of several randomized trials on extracorporeal cardiopulmonary resuscitation (ECPR) in patients with refractory out-of-hospital cardiac arrest were examined using frequentist methods, resulting in a dichotomous interpretation of results based on p-values rather than in the probability of clinically relevant treatment effects. To determine such a probability of a clinically relevant ECPR-based treatment effect on neurological outcomes, the authors of these trials performed a Bayesian meta-analysis of the totality of randomized ECPR evidence.
METHODS: A systematic search was applied to three electronic databases. Randomized trials that compared ECPR-based treatment with conventional CPR for refractory out-of-hospital cardiac arrest were included. The study was preregistered in INPLASY (INPLASY2023120060). The primary Bayesian hierarchical meta-analysis estimated the difference in 6-month neurologically favorable survival in patients with all rhythms, and a secondary analysis assessed this difference in patients with shockable rhythms (Bayesian hierarchical random-effects model). Primary Bayesian analyses were performed under vague priors. Outcomes were formulated as estimated median relative risks, mean absolute risk differences, and numbers needed to treat with corresponding 95% credible intervals (CrIs). The posterior probabilities of various clinically relevant absolute risk difference thresholds were estimated.
RESULTS: Three randomized trials were included in the analysis (ECPR, n = 209 patients; conventional CPR, n = 211 patients). The estimated median relative risk of ECPR for 6-month neurologically favorable survival was 1.47 (95%CrI 0.73-3.32) with a mean absolute risk difference of 8.7% (- 5.0; 42.7%) in patients with all rhythms, and the median relative risk was 1.54 (95%CrI 0.79-3.71) with a mean absolute risk difference of 10.8% (95%CrI - 4.2; 73.9%) in patients with shockable rhythms. The posterior probabilities of an absolute risk difference > 0% and > 5% were 91.0% and 71.1% in patients with all rhythms and 92.4% and 75.8% in patients with shockable rhythms, respectively.
CONCLUSION: The current Bayesian meta-analysis found a 71.1% and 75.8% posterior probability of a clinically relevant ECPR-based treatment effect on 6-month neurologically favorable survival in patients with all rhythms and shockable rhythms. These results must be interpreted within the context of the reported credible intervals and varying designs of the randomized trials.
REGISTRATION: INPLASY (INPLASY2023120060, December 14th, 2023, https://doi.org/10.37766/inplasy2023.12.0060 ).
参考来源
- Heuts S, Ubben JFH, Kawczynski MJ, et al. Extracorporeal cardiopulmonary resuscitation versus standard treatment for refractory out-of-hospital cardiac arrest: a Bayesian meta-analysis. Crit Care. 2024. PMID: 38961495. doi:10.1186/s13054-024-05008-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。